Table 2 Immunohistochemical results
From: Chemoradiotherapy is an alternative choice for patients with primary mediastinal seminoma
Antibody | No. of patients | Antibody | No. of patients | ||
|---|---|---|---|---|---|
Positive | Negative | Positive | Negative | ||
AE1/AE3 | 6 | 10 | CK8/18 | 0 | 2 |
AFP | 0 | 8 | D2-40 | 1 | 1 |
CD3 | 0 | 8 | EMA | 0 | 2 |
CD5 | 1 | 3 | HMB45 | 0 | 3 |
CD20 | 0 | 7 | hCG | 0 | 6 |
CD99 | 0 | 1 | LCA | 0 | 15 |
CD30 | 0 | 12 | Melan-pan | 0 | 2 |
CD117 | 14 | 1 | NSE | 0 | 2 |
CD163 | 1 | 0 | OCT3/4 | 5 | 0 |
CEA | 1 | 2 | P63 | 0 | 1 |
CgA | 0 | 2 | PAX5 | 0 | 2 |
ChA | 0 | 2 | PLAP | 18 | 0 |
CK5 | 0 | 1 | SALL4 | 6 | 0 |
CK7 | 1 | 1 | Syn | 0 | 4 |
CK18 | 2 | 0 | TdT | 0 | 6 |
CK19 | 2 | 3 | TTF-1 | 0 | 3 |
CK34βE12 | 0 | 1 | Vimentin | 1 | 4 |
CK5/6 | 0 | 2 | |||